Published in Hum Reprod on March 11, 2014
Discrepant diagnosis rate of array comparative genomic hybridization in thawed euploid blastocysts. J Assist Reprod Genet (2016) 0.91
The Impact of Biopsy on Human Embryo Developmental Potential during Preimplantation Genetic Diagnosis. Biomed Res Int (2016) 0.89
Consistent and reproducible outcomes of blastocyst biopsy and aneuploidy screening across different biopsy practitioners: a multicentre study involving 2586 embryo biopsies. Hum Reprod (2015) 0.86
The Future of Prenatal Diagnosis and Screening. J Clin Med (2014) 0.83
Microwells support high-resolution time-lapse imaging and development of preimplanted mouse embryos. Biomicrofluidics (2015) 0.83
Pre-implantation genetic testing in ART: who will benefit and what is the evidence? J Assist Reprod Genet (2016) 0.80
Biopsy of human morula-stage embryos: outcome of 215 IVF/ICSI cycles with PGS. PLoS One (2014) 0.79
Comparative study of single-nucleotide polymorphism array and next generation sequencing based strategies on triploid identification in preimplantation genetic diagnosis and screen. Oncotarget (2016) 0.75
Current status of preimplantation genetic diagnosis in Japan. Bioinformation (2015) 0.75
The accumulation of vitrified oocytes is a strategy to increase the number of euploid available blastocysts for transfer after preimplantation genetic testing. J Assist Reprod Genet (2017) 0.75
Medical genetics and genomic medicine in Greece: achievements and challenges. Mol Genet Genomic Med (2015) 0.75
Number of blastocysts biopsied as a predictive indicator to obtain at least one normal/balanced embryo following preimplantation genetic diagnosis with single nucleotide polymorphism microarray in translocation cases. J Assist Reprod Genet (2016) 0.75
The improvement of the best practice guidelines for preimplantation genetic diagnosis of cystic fibrosis: toward an international consensus. Eur J Hum Genet (2015) 0.75
A simple, less invasive stripper micropipetter-based technique for day 3 embryo biopsy. Fertil Res Pract (2016) 0.75
Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med (1998) 4.08
Assisted reproductive technology in Europe, 2008: results generated from European registers by ESHRE. Hum Reprod (2012) 2.28
Report on a consecutive series of 581 children born after blastomere biopsy for preimplantation genetic diagnosis. Hum Reprod (2009) 2.26
Yersinia enterocolitica infections and pork: the missing link. Lancet (1987) 2.15
[Results from 10 years of preimplantation-genetic diagnostics in The Netherlands]. Ned Tijdschr Geneeskd (2004) 2.11
Assisted reproductive technology in Europe, 2006: results generated from European registers by ESHRE. Hum Reprod (2010) 2.04
Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis (2012) 1.94
Assisted reproductive technology in Europe, 2009: results generated from European registers by ESHRE. Hum Reprod (2013) 1.91
Assisted reproductive technology in Europe, 2004: results generated from European registers by ESHRE. Hum Reprod (2008) 1.78
ESHRE PGD consortium best practice guidelines for amplification-based PGD. Hum Reprod (2010) 1.65
The ESHRE PGD Consortium: 10 years of data collection. Hum Reprod Update (2012) 1.62
Regionally clustered APC mutations are associated with a severe phenotype and occur at a high frequency in new mutation cases of adenomatous polyposis coli. Hum Mol Genet (1994) 1.52
Optimization and evaluation of single-cell whole-genome multiple displacement amplification. Hum Mutat (2006) 1.48
PGD for reciprocal and Robertsonian translocations using array comparative genomic hybridization. Hum Reprod (2011) 1.48
Pathogenesis and clinical management of hereditary non-polyposis colorectal cancer. Br J Surg (2002) 1.45
Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders. Hum Reprod (2005) 1.44
Tumor necrosis factor induces hyperphosphorylation of kinesin light chain and inhibits kinesin-mediated transport of mitochondria. J Cell Biol (2000) 1.43
The 55-kDa tumor necrosis factor receptor induces clustering of mitochondria through its membrane-proximal region. J Biol Chem (1998) 1.41
RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition. Cell Death Differ (2013) 1.36
ESHRE PGD Consortium data collection IX: cycles from January to December 2006 with pregnancy follow-up to October 2007. Hum Reprod (2009) 1.35
Cell membrane permeabilization and cellular collapse, followed by loss of dehydrogenase activity: early events in tumour necrosis factor-induced cytotoxicity. Cytokine (1993) 1.34
The causes of misdiagnosis and adverse outcomes in PGD. Hum Reprod (2009) 1.33
Assisted reproductive technology in Europe, 2003. Results generated from European registers by ESHRE. Hum Reprod (2007) 1.28
TNF-induced intracellular signaling leading to gene induction or to cytotoxicity by necrosis or by apoptosis. J Inflamm (1997) 1.27
Epithelial-mesenchymal transition process in human embryonic stem cells cultured in feeder-free conditions. Mol Hum Reprod (2006) 1.26
Cross border reproductive care in six European countries. Hum Reprod (2010) 1.25
Identification of the sex of human preimplantation embryos in two hours using an improved spreading method and fluorescent in-situ hybridization (FISH) using directly labelled probes. Hum Reprod (1994) 1.24
Assisted reproductive technology in Europe, 2007: results generated from European registers by ESHRE. Hum Reprod (2012) 1.23
ESHRE PGD consortium best practice guidelines for organization of a PGD centre for PGD/preimplantation genetic screening. Hum Reprod (2010) 1.22
Mosaicism of autosomes and sex chromosomes in morphologically normal, monospermic preimplantation human embryos. Prenat Diagn (1995) 1.22
Accreditation of the PGD laboratory. Hum Reprod (2010) 1.20
Embryo development and chromosomal anomalies after ICSI: effect of the injection procedure. Hum Reprod (2001) 1.17
ESHRE PGD Consortium data collection X: cycles from January to December 2007 with pregnancy follow-up to October 2008. Hum Reprod (2010) 1.17
Blastocyst biopsy versus cleavage stage biopsy and blastocyst transfer for preimplantation genetic diagnosis of beta-thalassaemia: a pilot study. Hum Reprod (2007) 1.14
GSK-3-specific inhibitor-supplemented hESC medium prevents the epithelial-mesenchymal transition process and the up-regulation of matrix metalloproteinases in hESCs cultured in feeder-free conditions. Mol Hum Reprod (2008) 1.12
New enrichment method for isolation of pathogenic Yersinia enterocolitica serogroup O:3 from pork. Appl Environ Microbiol (1988) 1.12
ESHRE's good practice guide for cross-border reproductive care for centers and practitioners. Hum Reprod (2011) 1.10
Bladder calculi in dogs and cats. Vet Rec (1998) 1.09
Impact of cleavage-stage embryo biopsy in view of PGD on human blastocyst implantation: a prospective cohort of single embryo transfers. Hum Reprod (2009) 1.08
Markers that define stemness in ESC are unable to identify the totipotent cells in human preimplantation embryos. Hum Reprod (2008) 1.07
ESHRE PGD Consortium data collection VIII: cycles from January to December 2005 with pregnancy follow-up to October 2006. Hum Reprod (2008) 1.05
Effect of oxygen concentration on human in-vitro fertilization and embryo culture. Hum Reprod (1999) 1.05
PGD in the lab for triplet repeat diseases - myotonic dystrophy, Huntington's disease and Fragile-X syndrome. Mol Cell Endocrinol (2001) 1.02
ESHRE PGD Consortium data collection XI: cycles from January to December 2008 with pregnancy follow-up to October 2009. Hum Reprod (2012) 1.02
ESHRE PGD Consortium data collection VI: cycles from January to December 2003 with pregnancy follow-up to October 2004. Hum Reprod (2006) 1.00
Comparison of in-vitro development of embryos originating from either conventional in-vitro fertilization or intracytoplasmic sperm injection. Hum Reprod (2000) 1.00
ESHRE PGD consortium data collection VII: cycles from January to December 2004 with pregnancy follow-up to October 2005. Hum Reprod (2008) 0.99
Embryo implantation after biopsy of one or two cells from cleavage-stage embryos with a view to preimplantation genetic diagnosis. Prenat Diagn (2000) 0.98
Quiescence-inducing and antiapoptotic activities of IL-15 enhance secondary CD4+ T cell responsiveness to antigen. J Immunol (1998) 0.97
ESHRE PGD Consortium data collection V: cycles from January to December 2002 with pregnancy follow-up to October 2003. Hum Reprod (2005) 0.96
Cumulative reproductive outcome after preimplantation genetic diagnosis: a report on 1498 couples. Hum Reprod (2009) 0.93
DNA methylation patterns of spermatozoa and two generations of offspring obtained after murine spermatogonial stem cell transplantation. Hum Reprod (2009) 0.91
SURF1 missense mutations promote a mild Leigh phenotype. Clin Genet (2009) 0.90
Cystic fibrosis in Greece: molecular diagnosis, haplotypes, prenatal diagnosis and carrier identification amongst high-risk individuals. Clin Genet (2003) 0.90
ESHRE PGD Consortium data collection XIII: cycles from January to December 2010 with pregnancy follow-up to October 2011. Hum Reprod (2015) 0.90
Novel universal approach for preimplantation genetic diagnosis of beta-thalassaemia in combination with HLA matching of embryos. Hum Reprod (2004) 0.89
Four novel SPG3A/atlastin mutations identified in autosomal dominant hereditary spastic paraplegia kindreds with intra-familial variability in age of onset and complex phenotype. Clin Genet (2009) 0.89
Preimplantation genetic diagnosis in 10 couples at risk for transmitting beta-thalassaemia major: clinical experience including the initiation of six singleton pregnancies. Prenat Diagn (1999) 0.89
Erythroid marrow activity and hemoglobin H levels in hemoglobin H disease. J Pediatr Hematol Oncol (1998) 0.88
A base substitution (T-->C) in codon 29 of the alpha 2-globin gene causes alpha thalassaemia. Br J Haematol (1993) 0.88
Prenatal diagnosis of the thalassaemia syndromes by rapid DNA analytical methods. Mol Hum Reprod (1997) 0.87
Real and expected delivery rates of patients with myotonic dystrophy undergoing intracytoplasmic sperm injection and preimplantation genetic diagnosis. Hum Reprod (2008) 0.87
Molecular studies of beta-thalassemia heterozygotes with raised Hb F levels. Hemoglobin (2000) 0.87
Phenotypic and molecular diversity of haemoglobin H disease: a Greek experience. Br J Haematol (2000) 0.87
ESHRE PGD consortium best practice guidelines for fluorescence in situ hybridization-based PGD. Hum Reprod (2010) 0.86
Preimplantation diagnosis for Huntington's disease (HD): clinical application and analysis of the HD expansion in affected embryos. Prenat Diagn (1998) 0.86
Preimplantation genetic diagnosis for cancer predisposition syndromes. Prenat Diagn (2007) 0.86
Birth of a healthy infant following trophectoderm biopsy from blastocysts for PGD of beta-thalassaemia major. Hum Reprod (2005) 0.85
Validation of preimplantation genetic diagnosis by PCR analysis: genotype comparison of the blastomere and corresponding embryo, implications for clinical practice. Mol Hum Reprod (2008) 0.84
Cryopreservation of embryos, blastocysts, and pregnancy rates of blastocysts derived from frozen-thawed embryos and frozen-thawed blastocysts. J Assist Reprod Genet (2001) 0.83
Current progress in preimplantation genetic diagnosis. J Assist Reprod Genet (1993) 0.83
Neonatal follow-up of 995 consecutively born children after embryo biopsy for PGD. Hum Reprod (2011) 0.83
Scanning of beta-globin gene for identification of beta-thalassemia mutation in Romanian population. J Cell Mol Med (2004) 0.83
Pregnancies following blastocyst stage transfer in PGD cycles at risk for beta-thalassaemic haemoglobinopathies. Hum Reprod (2002) 0.82
Severe hypertriglyceridaemia in diabetic ketoacidosis: clinical and genetic study. Diabet Med (2004) 0.82
Socio-demographic and fertility-related characteristics and motivations of oocyte donors in eleven European countries. Hum Reprod (2014) 0.82
Different geographic origins of Hb Constant Spring [alpha(2) codon 142 TAA-->CAA]. Haematologica (2001) 0.81
Allelic dropout caused by allele-specific amplification failure in single-cell PCR of the cystic fibrosis delta F508 deletion. J Assist Reprod Genet (1996) 0.81
Preimplantation diagnosis for X and Y normality in embryos from three Klinefelter patients. Hum Reprod (1996) 0.81
Pre-implantation diagnosis of genetic disease. Eur J Obstet Gynecol Reprod Biol (1996) 0.81
The interaction of alpha zero thalassaemia with Hb Icaria: three unusual cases of haemoglobinopathy H. Br J Haematol (1996) 0.81
Noninvasive prenatal diagnosis of beta-thalassaemia using individual fetal erythroblasts isolated from maternal blood after enrichment. Prenat Diagn (2007) 0.81
Mutation analysis of ten exons of the CFTR gene in Greek cystic fibrosis patients: characterization of 74.5% of CF alleles including one novel mutation. Hum Genet (1995) 0.81